Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionalpha2-adrenergic receptor activity

ADRA2A ADRA2B ADRA2C

6.97e-0731783GO:0004938
GeneOntologyMolecularFunctionG protein-coupled amine receptor activity

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

1.60e-06411786GO:0008227
GeneOntologyMolecularFunctionhormone binding

CALCR INSR ADRA2A ADRA2B ADRA2C ATP1A1 ATP1A3 HCRTR1

3.94e-061031788GO:0042562
GeneOntologyMolecularFunctionepinephrine binding

ADRA2A ADRA2B ADRA2C

1.37e-0561783GO:0051379
GeneOntologyMolecularFunctionalpha-adrenergic receptor activity

ADRA2A ADRA2B ADRA2C

1.37e-0561783GO:0004936
GeneOntologyMolecularFunctionamyloid-beta binding

CALCR INSR GRIN2B LRP8 FZD5 ATP1A3 EPHA4

3.60e-051021787GO:0001540
GeneOntologyMolecularFunctionadrenergic receptor activity

ADRA2A ADRA2B ADRA2C

7.98e-05101783GO:0004935
GeneOntologyMolecularFunctioncatecholamine binding

ADRA2A ADRA2B ADRA2C

1.87e-04131783GO:1901338
GeneOntologyMolecularFunctionserotonin binding

HTR1A HTR1B HTR1E

1.87e-04131783GO:0051378
GeneOntologyMolecularFunctionallyl-alcohol dehydrogenase activity

AKR1B10 AKR1B1

4.69e-0441782GO:0047655
GeneOntologyMolecularFunctionamine binding

HTR1A HTR1B HTR1E

8.23e-04211783GO:0043176
GeneOntologyMolecularFunctionG protein-coupled serotonin receptor activity

HTR1A HTR1B HTR1E

9.47e-04221783GO:0004993
GeneOntologyBiologicalProcessreceptor transactivation

ADRA2A ADRA2B ADRA2C

2.39e-0641753GO:0035624
GeneOntologyBiologicalProcessadenylate cyclase-inhibiting serotonin receptor signaling pathway

HTR1A HTR1B HTR1E

2.05e-0571753GO:0007198
GeneOntologyBiologicalProcessnegative regulation of amine transport

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

3.08e-05431755GO:0051953
GeneOntologyBiologicalProcessactivation of protein kinase B activity

INSR ADRA2A ADRA2B ADRA2C

5.51e-05251754GO:0032148
GeneOntologyBiologicalProcessnegative regulation of epinephrine secretion

ADRA2A ADRA2B ADRA2C

6.90e-05101753GO:0032811
GeneOntologyBiologicalProcessnegative regulation of uterine smooth muscle contraction

ADRA2A ADRA2C

7.16e-0521752GO:0070473
GeneOntologyBiologicalProcessadenylate cyclase-inhibiting G protein-coupled receptor signaling pathway

ADCY4 HTR1A HTR1B HTR1E ADRA2A GPR176

9.18e-05861756GO:0007193
GeneOntologyBiologicalProcessnegative regulation of norepinephrine secretion

ADRA2A ADRA2B ADRA2C

9.42e-05111753GO:0010700
GeneOntologyBiologicalProcessregulation of epinephrine secretion

ADRA2A ADRA2B ADRA2C

9.42e-05111753GO:0014060
GeneOntologyBiologicalProcessregulation of uterine smooth muscle contraction

ADRA2A ADRA2B ADRA2C

1.25e-04121753GO:0070472
GeneOntologyBiologicalProcessregulation of serotonin secretion

HTR1A HTR1B MAOB

1.25e-04121753GO:0014062
GeneOntologyBiologicalProcessuterine smooth muscle contraction

ADRA2A ADRA2B ADRA2C

1.61e-04131753GO:0070471
GeneOntologyBiologicalProcessepinephrine secretion

ADRA2A ADRA2B ADRA2C

1.61e-04131753GO:0048242
GeneOntologyBiologicalProcessadenylate cyclase-modulating G protein-coupled receptor signaling pathway

ADCY4 HTR1A HTR1B HTR1E CALCR ADRA2A ADRA2B ADRA2C MAPK7 GPR176

1.72e-0428617510GO:0007188
GeneOntologyCellularComponentaxon

HTR1A HTR1B CALCR RASGRF1 MYCBP2 USP9X PPP1R9A INSR GRIN2B LRP8 ADRA2A ADRA2C PTPRN FZD5 SCN3A C4A C4B ATP1A1 ATP1A3 CNGA3 PALLD EPHA4

9.78e-0689118122GO:0030424
GeneOntologyCellularComponentneuronal cell body

HTR1A CALCR MAOB RASGRF1 PPP1R9A INSR GRIN2B LRP8 SORT1 ADRA2A ADRA2C PTPRN FZD5 SCN3A C4A C4B ATP1A3 CNGA3 PALLD EPHA4

3.91e-0583518120GO:0043025
GeneOntologyCellularComponentcell body

HTR1A CALCR MAOB RASGRF1 PPP1R9A INSR GRIN2B LRP8 SORT1 PITPNM1 ADRA2A ADRA2C PTPRN FZD5 SCN3A C4A C4B ATP1A3 CNGA3 PALLD EPHA4

5.73e-0592918121GO:0044297
GeneOntologyCellularComponentsomatodendritic compartment

ADCY4 HTR1A HTR1B HTR1E CALCR MAOB RASGRF1 PPP1R9A INSR LAMA2 GRIN2B LRP8 SORT1 ADRA2A ADRA2C PTPRN FZD5 SCN3A C4A C4B ATP1A3 CNGA3 PALLD EPHA4

1.59e-04122818124GO:0036477
GeneOntologyCellularComponentphotoreceptor inner segment membrane

ATP1A1 ATP1A3

4.42e-0441812GO:0060342
GeneOntologyCellularComponentdendrite

ADCY4 HTR1A HTR1B HTR1E MAOB RASGRF1 PPP1R9A INSR LAMA2 GRIN2B LRP8 SORT1 FZD5 C4A C4B ATP1A3 CNGA3 EPHA4

4.87e-0485818118GO:0030425
GeneOntologyCellularComponentdendritic tree

ADCY4 HTR1A HTR1B HTR1E MAOB RASGRF1 PPP1R9A INSR LAMA2 GRIN2B LRP8 SORT1 FZD5 C4A C4B ATP1A3 CNGA3 EPHA4

5.00e-0486018118GO:0097447
HumanPhenoHypoplasia of the fovea

DCT TYR FZD5 CNGB3 HPS5 CNGA3

1.32e-0633576HP:0007750
HumanPhenoAplasia/Hypoplasia of the fovea

DCT TYR FZD5 CNGB3 HPS5 CNGA3

1.32e-0633576HP:0008060
HumanPhenoAplasia/Hypoplasia of the macula

DCT TYR FZD5 CNGB3 HPS5 CNGA3

2.30e-0553576HP:0008059
HumanPhenoAbnormal foveal morphology

DCT TYR FZD5 CNGB3 HPS5 CNGA3

4.71e-0560576HP:0000493
Domain-

FBXW9 IFT172 BIRC6 WDFY4 DDB1 WDR43 SORT1 CIAO1 WRAP73 IFT80 HPS5 DCAF4 DCAF4L1 PLXNB3

3.67e-06333177142.130.10.10
DomainWD40/YVTN_repeat-like_dom

FBXW9 IFT172 BIRC6 WDFY4 DDB1 WDR43 SORT1 CIAO1 WRAP73 IFT80 HPS5 DCAF4 DCAF4L1 PLXNB3

3.93e-0633517714IPR015943
DomainDDHD

PITPNM1 SEC23IP DDHD2

1.64e-0561773PF02862
DomainDDHD

PITPNM1 SEC23IP DDHD2

1.64e-0561773PS51043
DomainDDHD_dom

PITPNM1 SEC23IP DDHD2

1.64e-0561773IPR004177
DomainDDHD

PITPNM1 SEC23IP DDHD2

1.64e-0561773SM01127
DomainGalactose-bd-like

MYCBP2 LAMA2 F8 NCCRP1 PTPRM NGLY1 EPHA4

3.12e-05941777IPR008979
Domain5HT_rcpt

HTR1A HTR1B HTR1E

6.74e-0591773IPR002231
DomainNR5_fam

NR5A2 NR5A1

8.93e-0521772IPR016355
DomainADR_fam

ADRA2A ADRA2B ADRA2C

9.56e-05101773IPR002233
Domain7TM_GPCR_Srsx

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C HCRTR1

9.57e-051121777SM01381
DomainMtf2_C_dom

MTF2 PHF1

2.66e-0431772IPR025894
Domain-

DCT TYR

2.66e-04317721.10.1280.10
DomainUnchr_di-copper_centre

DCT TYR

2.66e-0431772IPR008922
DomainTYROSINASE_1

DCT TYR

2.66e-0431772PS00497
DomainTYROSINASE_2

DCT TYR

2.66e-0431772PS00498
DomainTyrosinase

DCT TYR

2.66e-0431772PF00264
DomainMtf2_C

MTF2 PHF1

2.66e-0431772PF14061
DomainTyrosinase_Cu-bd

DCT TYR

2.66e-0431772IPR002227
DomainSAM_DOMAIN

PPP1R9A BFAR SEC23IP DDHD2 GAREM1 EPHA4

2.88e-04951776PS50105
DomainSAM

PPP1R9A BFAR SEC23IP DDHD2 GAREM1 EPHA4

3.22e-04971776IPR001660
DomainWD40_repeat_dom

FBXW9 IFT172 WDFY4 DDB1 WDR43 CIAO1 IFT80 HPS5 DCAF4 DCAF4L1

5.53e-0429717710IPR017986
Domain-

MYCBP2 LAMA2 F8 NCCRP1 EPHA4

6.45e-047317752.60.120.260
DomainCyclin-like

RBL1 CCNJ CASD1 CCNE2

7.21e-04431774IPR013763
DomainWD40

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

8.35e-042591779PF00400
DomainSAM/pointed

PPP1R9A BFAR SEC23IP DDHD2 GAREM1 EPHA4

8.73e-041171776IPR013761
DomainAnaphylatoxin_comp_syst

C4A C4B

8.76e-0451772IPR018081
DomainPHR

BTBD6 MYCBP2

8.76e-0451772IPR012983
DomainAnaphylatoxn_comp_syst_dom

C4A C4B

8.76e-0451772IPR001840
DomainYTH

YTHDF1 YTHDF2

8.76e-0451772PF04146
DomainPHR

BTBD6 MYCBP2

8.76e-0451772PF08005
DomainYTH_domain

YTHDF1 YTHDF2

8.76e-0451772IPR007275
DomainYTH

YTHDF1 YTHDF2

8.76e-0451772PS50882
DomainWD40

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

1.06e-032681779SM00320
DomainWD40_repeat

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

1.18e-032721779IPR001680
DomainP-type_ATPase_IIC

ATP1A1 ATP1A3

1.31e-0361772IPR005775
DomainWD_REPEATS_1

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

1.37e-032781779PS00678
DomainWD_REPEATS_2

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

1.40e-032791779PS50082
DomainWD_REPEATS_REGION

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

1.40e-032791779PS50294
DomainSAM

PPP1R9A BFAR SEC23IP DDHD2 EPHA4

1.50e-03881775SM00454
DomainARM-type_fold

USP34 USP9X IFT172 WDFY4 PPP2R1B ELMO3 IPO9 MROH6 LTN1 INTS4

1.51e-0333917710IPR016024
DomainANATO

C4A C4B

1.82e-0371772SM00104
DomainANAPHYLATOXIN_2

C4A C4B

1.82e-0371772PS01178
DomainANAPHYLATOXIN_1

C4A C4B

1.82e-0371772PS01177
DomainANATO

C4A C4B

1.82e-0371772PF01821
DomainAnaphylatoxin/fibulin

C4A C4B

1.82e-0371772IPR000020
DomainMacrogloblnA2_thiol-ester-bond

C4A C4B

2.41e-0381772IPR019565
DomainThiol-ester_cl

C4A C4B

2.41e-0381772PF10569
DomainMacrogloblnA2_CS

C4A C4B

2.41e-0381772IPR019742
DomainIg-like_fold

MYCBP2 INSR CCDC141 IL1RL2 MFAP3 PTPRM CD226 IGHM CD101 MYBPHL PALLD PLXNB3 IGSF3 EPHA4 MYBPC3

3.01e-0370617715IPR013783
Domain-

PPP1R9A BFAR SEC23IP DDHD2 EPHA4

3.39e-0310617751.10.150.50
DomainKringle-like

F2 PLA2R1 IGF2R

3.39e-03321773IPR013806
Domain-

ATP10A ATP1A1 ATP1A3

3.39e-033217733.40.1110.10
Domain-

ATP10A ATP1A1 ATP1A3

3.39e-033217732.70.150.10
DomainCNMP_BINDING_1

KCNH8 CNGB3 CNGA3

3.39e-03321773PS00888
DomainCNMP_BINDING_2

KCNH8 CNGB3 CNGA3

3.39e-03321773PS00889
DomainALDOKETO_REDUCTASE_1

AKR1B10 AKR1B1

3.82e-03101772PS00798
DomainA2M

C4A C4B

3.82e-03101772PF00207
DomainA2M_N_2

C4A C4B

3.82e-03101772IPR011625
DomainA2M_comp

C4A C4B

3.82e-03101772IPR011626
DomainA2M_recep

C4A C4B

3.82e-03101772PF07677
DomainA2M_comp

C4A C4B

3.82e-03101772PF07678
DomainALDOKETO_REDUCTASE_2

AKR1B10 AKR1B1

3.82e-03101772PS00062
DomainALDOKETO_REDUCTASE_3

AKR1B10 AKR1B1

3.82e-03101772PS00063
DomainA2M_N

C4A C4B

3.82e-03101772PF01835
DomainA2M_N

C4A C4B

3.82e-03101772IPR002890
DomainA-macroglobulin_rcpt-bd

C4A C4B

3.82e-03101772IPR009048
DomainALPHA_2_MACROGLOBULIN

C4A C4B

3.82e-03101772PS00477
DomainAldo/ket_reductase_CS

AKR1B10 AKR1B1

3.82e-03101772IPR018170
DomainAldo/keto_reductase

AKR1B10 AKR1B1

3.82e-03101772IPR020471
DomainA2M_N_2

C4A C4B

3.82e-03101772PF07703
DomainMacroglobln_a2

C4A C4B

3.82e-03101772IPR001599
DomainSAM_1

BFAR SEC23IP DDHD2 GAREM1

3.96e-03681774PF00536
DomaincNMP

KCNH8 CNGB3 CNGA3

4.04e-03341773SM00100
DomaincNMP_binding

KCNH8 CNGB3 CNGA3

4.04e-03341773PF00027
DomainARM-like

USP9X WDFY4 PPP2R1B ELMO3 IPO9 MROH6 LTN1 INTS4

4.30e-032701778IPR011989
Domain-

MYCBP2 INSR CCDC141 IL1RL2 MFAP3 PTPRM CD226 CD101 MYBPHL PALLD PLXNB3 IGSF3 EPHA4 MYBPC3

4.34e-03663177142.60.40.10
DomaincNMP-bd_dom

KCNH8 CNGB3 CNGA3

4.38e-03351773IPR000595
DomainATPase_P-typ_cyto_domN

ATP10A ATP1A1 ATP1A3

4.38e-03351773IPR023299
DomainCNMP_BINDING_3

KCNH8 CNGB3 CNGA3

4.38e-03351773PS50042
DomainLaminin_G_1

LAMA2 PROS1

4.64e-03111772PF00054
DomainATPase_P-typ_P_site

ATP10A ATP1A1 ATP1A3

4.75e-03361773IPR018303
DomainP_typ_ATPase

ATP10A ATP1A1 ATP1A3

4.75e-03361773IPR001757
DomainATPASE_E1_E2

ATP10A ATP1A1 ATP1A3

4.75e-03361773PS00154
DomainATPase_P-typ_transduc_dom_A

ATP10A ATP1A1 ATP1A3

5.13e-03371773IPR008250
DomainE1-E2_ATPase

ATP10A ATP1A1 ATP1A3

5.13e-03371773PF00122
DomaincNMP-bd-like

KCNH8 CNGB3 CNGA3

5.53e-03381773IPR018490
DomainCYCLIN

RBL1 CCNJ CCNE2

5.53e-03381773SM00385
DomainMAPK

MAPK7 NLK

5.54e-03121772PS01351
DomainCoagulation_fac_subgr_Gla_dom

F2 PROS1

5.54e-03121772IPR017857
DomainMAP_kinase_CS

MAPK7 NLK

5.54e-03121772IPR003527
Domain-

F2 PROS1

5.54e-031217724.10.740.10
DomainLDLR_class-A_CS

LRP1B LRP8 MALRD1

6.39e-03401773IPR023415
Domain-

RBL1 CCNJ CCNE2

6.39e-034017731.10.472.10
Domain-

PLA2R1 IGF2R

6.50e-031317722.10.10.10
DomainHAD-like_dom

ATP10A PITPNM1 ATP1A1 ATP1A3

6.75e-03791774IPR023214
DomainIG_LIKE

CCDC141 IL1RL2 MFAP3 PTPRM CD226 IGHM CD101 MYBPHL PALLD IGSF3 MYBPC3

7.27e-0349117711PS50835
DomainFN_type2_col-bd

PLA2R1 IGF2R

7.54e-03141772IPR000562
DomainFN2_2

PLA2R1 IGF2R

7.54e-03141772PS51092
DomainVitD_rcpt

NR5A2 NR5A1

7.54e-03141772IPR000324
PathwayWP_MONOAMINE_GPCRS

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

6.45e-07331366M39585
PathwayREACTOME_AMINE_LIGAND_BINDING_RECEPTORS

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

2.85e-06421366M5868
PathwayWP_MONOAMINE_GPCRS

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

1.08e-05311365MM15871
PathwayWP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE

ADCY4 ADRA2A ADRA2B ADRA2C

1.38e-05161364M39849
PathwayREACTOME_AMINE_LIGAND_BINDING_RECEPTORS

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

4.96e-05421365MM14971
PathwayKEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION

PRSS2 HTR1A HTR1B HTR1E CALCR GRIN2B F2 ADRA2A ADRA2B ADRA2C HCRTR1

6.52e-0527213611M13380
PathwayREACTOME_ADRENOCEPTORS

ADRA2A ADRA2B ADRA2C

7.07e-0591363M27302
PathwayREACTOME_ADRENOCEPTORS

ADRA2A ADRA2B ADRA2C

7.07e-0591363MM15009
PathwayREACTOME_SEROTONIN_RECEPTORS

HTR1A HTR1B HTR1E

1.81e-04121363M6034
PathwayREACTOME_G_ALPHA_Z_SIGNALLING_EVENTS

ADCY4 ADRA2A ADRA2B ADRA2C

2.73e-04331364MM15058
PathwayWP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY

HTR1A HTR1B HTR1E RASGRF1

4.28e-04371364M42558
PathwayREACTOME_PLATELET_AGGREGATION_PLUG_FORMATION

F2 ADRA2A ADRA2B ADRA2C

4.74e-04381364MM15456
PathwayREACTOME_PLATELET_AGGREGATION_PLUG_FORMATION

F2 ADRA2A ADRA2B ADRA2C

5.25e-04391364M10735
PathwayKEGG_COMPLEMENT_AND_COAGULATION_CASCADES

F2 F8 C4A C4B PROS1

5.32e-04691365M16894
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

USP34 DPY19L3 ARV1 MYCBP2 GNPTAB POMGNT1 EMC8 GALNT7 LRP1B DDB1 STT3B LRP8 SORT1 SLC30A7 TMX1 PLA2R1 MYOF IGF2R LTN1 PKD2 SEL1L3 CERCAM C4A NGLY1 SELENOI ATP1A1 CHPF PALLD IGSF3 PROS1

1.63e-1212011843035696571
Pubmed

Distribution of mRNA encoding three alpha 2-adrenergic receptor subtypes in the developing mouse embryo suggests a role for the alpha 2A subtype in apoptosis.

ADRA2A ADRA2B ADRA2C

1.46e-07318439415717
Pubmed

Direct inhibition of cardiac hyperpolarization-activated cyclic nucleotide-gated pacemaker channels by clonidine.

ADRA2A ADRA2B ADRA2C

1.46e-073184317261653
Pubmed

Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells.

ADRA2A ADRA2B ADRA2C

1.46e-073184312946937
Pubmed

Resting sympathetic nerve activity is related to age, sex and arterial pressure but not to α2-adrenergic receptor subtype.

ADRA2A ADRA2B ADRA2C

1.46e-073184320613626
Pubmed

Nefopam but not physostigmine affects the thermoregulatory response in mice via alpha(2)-adrenoceptors.

ADRA2A ADRA2B ADRA2C

1.46e-073184319744502
Pubmed

Function of brain α2B-adrenergic receptor characterized with subtype-selective α2B antagonist and KO mice.

ADRA2A ADRA2B ADRA2C

1.46e-073184327751959
Pubmed

Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury.

ADRA2A ADRA2B ADRA2C

1.46e-073184337841583
Pubmed

Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice.

ADRA2A ADRA2B ADRA2C

1.46e-073184311927164
Pubmed

Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.

ADRA2A ADRA2B ADRA2C

1.46e-073184311125002
Pubmed

Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes.

ADRA2A ADRA2B ADRA2C

1.46e-073184312764077
Pubmed

Effect on diurnal intraocular pressure variation of eliminating the alpha-2 adrenergic receptor subtypes in the mouse.

ADRA2A ADRA2B ADRA2C

1.46e-073184318326714
Pubmed

Delayed transactivation of the receptor for nerve growth factor is required for sustained signaling and differentiation by alpha2-adrenergic receptors in transfected PC12 cells.

ADRA2A ADRA2B ADRA2C

1.46e-073184317215105
Pubmed

Expression of alpha 2-adrenergic receptor subtypes in the mouse brain: evaluation of spatial and temporal information imparted by 3 kb of 5' regulatory sequence for the alpha 2A AR-receptor gene in transgenic animals.

ADRA2A ADRA2B ADRA2C

1.46e-07318438843087
Pubmed

Alpha2-adrenoceptor subtypes involved in the regulation of catecholamine release from the adrenal medulla of mice.

ADRA2A ADRA2B ADRA2C

1.46e-073184317075569
Pubmed

Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene.

ADRA2A ADRA2B ADRA2C

1.46e-073184315592690
Pubmed

Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice.

ADRA2A ADRA2B ADRA2C

1.46e-073184310385696
Pubmed

Association between common genetic variants of α2A-, α2B-, and α2C-adrenergic receptors and ischemic stroke.

ADRA2A ADRA2B ADRA2C

1.46e-073184322560155
Pubmed

Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission.

ADRA2A ADRA2B ADRA2C

1.46e-073184310647009
Pubmed

Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice.

ADRA2A ADRA2B ADRA2C

1.46e-073184311181434
Pubmed

Insertion/insertion genotype of α(2B)-adrenergic receptor gene polymorphism is associated with silent myocardial ischemia in patients with type 2 diabetes mellitus.

ADRA2A ADRA2B ADRA2C

1.46e-073184320692245
Pubmed

Association between Common Genetic Variants of α2A-, α2B-, and α2C-Adrenergic Receptors and Orthostatic Hypotension.

ADRA2A ADRA2B ADRA2C

1.46e-073184326427149
Pubmed

Novel cell surface genes expressed in the stomach primordium during gastrointestinal morphogenesis of mouse embryos.

ADRA2A ADRA2B ADRA2C FZD5

5.22e-0713184422266179
Pubmed

Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response.

ADRA2A ADRA2B ADRA2C

5.80e-074184315920038
Pubmed

The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha2-adrenergic receptor subtypes.

ADRA2A ADRA2B ADRA2C

5.80e-074184310224112
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

USP34 DPY19L3 USP9X POMGNT1 CHD8 EMC8 LRP8 NUP205 SORT1 TMX1 MYOF IGF2R PTPRM SEC23IP LTN1 NR5A2 INTS4 AKR1B1 ABHD16A PROS1

1.01e-0610611842033845483
Pubmed

Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance.

ADRA2A ADRA2B ADRA2C

1.45e-065184315719258
Pubmed

Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation.

ADRA2A ADRA2B ADRA2C

1.45e-065184319477270
Pubmed

Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin.

ADRA2A ADRA2B ADRA2C

1.45e-065184311154706
Pubmed

Structural insights into the ligand binding and Gi coupling of serotonin receptor 5-HT5A.

HTR1A HTR1B HTR1E

1.45e-065184335610220
Pubmed

G(z) signaling: emerging divergence from G(i) signaling.

ADRA2A ADRA2B ADRA2C

1.45e-065184311313909
Pubmed

Interaction of the amyloid precursor like protein 1 with the alpha2A-adrenergic receptor increases agonist-mediated inhibition of adenylate cyclase.

ADRA2A ADRA2B ADRA2C

1.45e-065184316531006
Pubmed

Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.

ADRA2A ADRA2B ADRA2C

1.45e-065184320814988
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

PLSCR4 DPY19L3 RBL1 PPP1R9A EMC8 BIRC6 STT3B LRP8 SORT1 IGF2R PTPRM SEC23IP ITPRIP MRPL38 ABHD16A IGSF3

1.60e-067191841635337019
Pubmed

Association study of the serotoninergic system in migraine in the Spanish population.

HTR1A HTR1B HTR1E MAOB

2.19e-0618184419455600
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SYNM GNPTAB ZFC3H1 BIRC6 WDFY4 ATP10A JMJD1C CEP68 MYOF IPO9 LTN1 DDHD2 PALLD

2.55e-064931841315368895
Pubmed

A novel interaction between adrenergic receptors and the alpha-subunit of eukaryotic initiation factor 2B.

ADRA2A ADRA2B ADRA2C

2.88e-06618439235896
Pubmed

α2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5.

ADRA2A ADRA2B ADRA2C

2.88e-066184322933299
Pubmed

Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro.

IGHM C4A C4B

2.88e-066184315597324
Pubmed

B cell subsets contribute to renal injury and renal protection after ischemia/reperfusion.

IGHM C4A C4B

2.88e-066184320810984
Pubmed

Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes.

ADRA2A ADRA2B ADRA2C

2.88e-066184317636168
Pubmed

Placental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryo.

ADRA2A ADRA2B ADRA2C

2.88e-066184312068299
Pubmed

Complexity at the mouse minor histocompatibility locus H-4.

TYR C4A C4B

2.88e-06618432137109
Pubmed

Association between genetic polymorphisms of adrenergic receptor and diurnal intraocular pressure in Japanese normal-tension glaucoma.

ADRA2A ADRA2B ADRA2C

5.02e-067184320705341
Pubmed

A study of candidate genotypes associated with dyspepsia in a U.S. community.

HTR1A ADRA2A ADRA2C

5.02e-067184316464220
Pubmed

Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.

PRSS2 DPY19L3 EPPK1 MYCBP2 RBL1 USP9X YTHDF1 RECQL5 SEC23IP LTN1 C4A SYVN1 CHPF

5.93e-065331841325544563
Pubmed

Genetical genomic determinants of alcohol consumption in rats and humans.

HTR1A HTR1B MAOB GRIN2B ADRA2A ADRA2B ADRA2C

6.32e-06130184719874574
Pubmed

Impaired antibody response causes persistence of prototypic T cell-contained virus.

IGHM C4A C4B

8.00e-068184319355789
Pubmed

Cardiac function in genetically engineered mice with altered adrenergic receptor signaling.

ADRA2A ADRA2B ADRA2C

8.00e-06818439139936
Pubmed

A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.

USP9X GALNT7 STT3B SLC30A7 TMX1 MYOF IGF2R ABCG2 ATP1A1 SYVN1 YTHDF2

8.61e-063921841133144569
Pubmed

The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine.

INSR YTHDF1 FZD5 YTHDF2

8.79e-0625184435874829
Pubmed

The CRL4DCAF6 E3 ligase ubiquitinates CtBP1/2 to induce apoptotic signalling and promote intervertebral disc degeneration.

USP9X CHD8 CLDN7 DDB1 IPO9 CIAO1 SYVN1 NLK

1.18e-05199184836688959
Pubmed

Surviving mousepox infection requires the complement system.

IGHM C4A C4B

1.20e-059184319112490
Pubmed

Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo.

ADRA2A ADRA2B ADRA2C

1.20e-059184321209093
Pubmed

Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.

HTR1B ADRA2A ADRA2B ADRA2C

1.41e-0528184419352218
Pubmed

A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory.

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

1.43e-0558184511140838
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

USP34 CHD8 EMC8 ZFC3H1 GALNT7 JMJD1C STT3B NUP205 SLC30A7 TMX1 IPO9 IGF2R ITPRIP ZCCHC7 ATP1A1 SYVN1 ABHD16A NLK IGSF3

2.32e-0512031841929180619
Pubmed

USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

EPPK1 USP9X DDB1

2.33e-0511184331073027
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

STT3B NUP205 IGF2R SEL1L3 ITPRIP CERCAM TFB2M NGLY1 ATP1A1 CHPF YTHDF2 IGSF3 PROS1

2.58e-056131841322268729
Pubmed

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

C4A C4B

2.78e-052184222737222
Pubmed

Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice.

HTR1A HTR1B

2.78e-052184212555283
Pubmed

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

C4A C4B

2.78e-052184216565498
Pubmed

Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.

C4A C4B

2.78e-052184215998580
Pubmed

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.

C4A C4B

2.78e-052184219062096
Pubmed

Do allelic variants in alpha2A and alpha2C adrenergic receptors predispose to hypertension in blacks?

ADRA2A ADRA2C

2.78e-052184216636200
Pubmed

Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians.

AKR1B10 AKR1B1

2.78e-052184215745835
Pubmed

Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levels.

F2 PROS1

2.78e-052184216493484
Pubmed

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

C4A C4B

2.78e-052184219933335
Pubmed

Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.

C4A C4B

2.78e-05218422459207
Pubmed

Antigen-induced B cell apoptosis is independent of complement C4.

C4A C4B

2.78e-052184217645767
Pubmed

Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

F8 PROS1

2.78e-05218427620160
Pubmed

Anti-DNA autoreactivity in C4-deficient mice.

C4A C4B

2.78e-052184212207352
Pubmed

Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype.

HTR1A HTR1B

2.78e-05218421559993
Pubmed

Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

C4A C4B

2.78e-052184227758680
Pubmed

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

C4A C4B

2.78e-052184222387014
Pubmed

Regulation of human cone cyclic nucleotide-gated channels by endogenous phospholipids and exogenously applied phosphatidylinositol 3,4,5-trisphosphate.

CNGB3 CNGA3

2.78e-052184217018579
Pubmed

Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

HTR1A HTR1B

2.78e-05218429826725
Pubmed

Novel CNGA3 and CNGB3 mutations in two Pakistani families with achromatopsia.

CNGB3 CNGA3

2.78e-052184220454696
Pubmed

Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

C4A C4B

2.78e-052184223749435
Pubmed

The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells.

C4B PROS1

2.78e-052184215096498
Pubmed

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.

C4A C4B

2.78e-052184223918728
Pubmed

Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.

C4B PROS1

2.78e-052184215456488
Pubmed

Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c.

ADRA2B ADRA2C

2.78e-05218428670422
Pubmed

Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

C4A C4B

2.78e-05218423037333
Pubmed

Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.

C4A C4B

2.78e-052184211726230
Pubmed

Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.

C4A C4B

2.78e-05218424216347
Pubmed

Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineurs.

HTR1A HTR1B

2.78e-052184217417740
Pubmed

Sequence determination of the thiolester site of the fourth component of human complement.

C4A C4B

2.78e-05218426950384
Pubmed

Disease Progression in CNGA3 and CNGB3 Retinopathy; Characteristics of Slovenian Cohort and Proposed OCT Staging Based on Pooled Data from 126 Patients from 7 Studies.

CNGB3 CNGA3

2.78e-052184234449556
Pubmed

N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.

YTHDF1 YTHDF2

2.78e-052184226046440
Pubmed

Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.

C4A C4B

2.78e-05218428660986
Pubmed

Associations between high factor VIII and low free protein S levels with traditional arterial thrombotic risk factors and their risk on arterial thrombosis: results from a retrospective family cohort study.

F8 PROS1

2.78e-052184220705334
Pubmed

Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.

C4A C4B

2.78e-05218428428773
Pubmed

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

C4A C4B

2.78e-052184224638111
Pubmed

Transcriptional repression of C4 complement by hepatitis C virus proteins.

C4A C4B

2.78e-052184221345967
Pubmed

Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure.

ADRA2A ADRA2C

2.78e-052184218632114
Pubmed

Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding.

ADRA2A ADRA2C

2.78e-05218421353249
Pubmed

Genetic basis of total colourblindness among the Pingelapese islanders.

CNGB3 CNGA3

2.78e-052184210888875
Pubmed

All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides.

ATP1A1 ATP1A3

2.78e-052184211546672
Pubmed

Retinal morphology of patients with achromatopsia during early childhood: implications for gene therapy.

CNGB3 CNGA3

2.78e-052184224676353
GeneFamilyAdrenoceptors

ADRA2A ADRA2B ADRA2C

3.53e-0591383169
GeneFamily5-hydroxytryptamine receptors, G protein-coupled

HTR1A HTR1B HTR1E

1.18e-04131383170
GeneFamilyWD repeat domain containing

FBXW9 IFT172 WDFY4 WDR43 CIAO1 WRAP73 IFT80 DCAF4 DCAF4L1

1.85e-042621389362
GeneFamilySterile alpha motif domain containing

PPP1R9A BFAR SEC23IP DDHD2 EPHA4

5.68e-04881385760
GeneFamilyATPase Na+/K+ transporting subunits

ATP1A1 ATP1A3

1.18e-03713821208
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

MFAP3 PTPRM CD101 MYBPHL PALLD MYBPC3

1.48e-031611386593
GeneFamilyFibronectin type III domain containing|I-set domain containing|Myosin binding proteins

MYBPHL MYBPC3

1.57e-0381382658
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

C4A C4B

2.01e-03913821234
GeneFamilyCyclic nucleotide gated channels

CNGB3 CNGA3

2.50e-03101382250
GeneFamilyGlycosyltransferase family 6|Blood group antigens

C4A C4B ABCG2

2.80e-03371383454
GeneFamilyGla domain containing

F2 PROS1

4.27e-031313821250
GeneFamilyLow density lipoprotein receptors

LRP1B LRP8

4.27e-03131382634
GeneFamilyC-type lectin domain family

CLEC7A PLA2R1 ASGR1

5.52e-03471383494
GeneFamilyCD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing

TICAM1 IL1RL2

5.69e-031513821296
GeneFamilyAldo-keto reductases

AKR1B10 AKR1B1

5.69e-03151382399
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

3.46e-0917818210c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCellCOVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

5.02e-09185182104a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCellCOVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

5.02e-091851821036ce23893915f5c380cca39b2c33a516edf31c3a
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

5.86e-0918818210c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

6.48e-091901821091bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 TMEM255B F8 CEP68 PIEZO2 SCN3A NR5A2 SNTG2

4.17e-081731829dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TMEM45A CFAP54 IGHM SEL1L3 CERCAM C4A C4B SYVN1 CHPF

8.13e-081871829c80e03d5aa498b4eecbc46565fabf9b5be10c71c
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B PIEZO2 SCN3A NR5A2 SNTG2

9.31e-0819018296e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCellTracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADCY4 GRIN2B CCDC141 TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

1.21e-07196182909a7edf4a7defb7fe70d9777dd9500ee8421ff31
ToppCellTracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADCY4 GRIN2B CCDC141 TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

1.21e-071961829e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755
ToppCellBronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLSCR4 ADCY4 GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

1.32e-071981829fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCellBronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLSCR4 ADCY4 GRIN2B TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

1.32e-071981829b3a020522e064bb61949d38e442f24026e339364
ToppCellControl-Neuronal_cells|Control / group, cell type (main and fine annotations)

PLSCR4 ADCY4 GRIN2B TMEM255B PIEZO2 SCN3A NR5A2 SNTG2

6.70e-071761828c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCellControl-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations)

PLSCR4 ADCY4 GRIN2B TMEM255B PIEZO2 SCN3A NR5A2 SNTG2

6.70e-07176182898c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SYNM GRIN2B TMEM255B F8 PIEZO2 PTPRM ASGR1 SNTG2

6.70e-0717618285d3b2395bb842eea39175f5af6a4c76527e2fc31
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM TMEM255B F8 SCN3A NR5A2 SNTG2

9.75e-071851828f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B PIEZO2 NR5A2 SNTG2

1.06e-0618718281e52d3d9d664c813d859b5b75e4c07b218818f95
ToppCellEndothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 SYNM TMEM255B F8 SCN3A NR5A2 SNTG2

1.10e-06188182880910dcbb51990f2baed240f319456c0d3fa2065
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLSCR4 SYNM TMEM255B F8 PIEZO2 SCN3A NR5A2 SNTG2

1.10e-0618818282db80767903703e7e0a1a37c598f7877a909ee94
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 GRIN2B F8 PIEZO2 SCN3A NR5A2 SNTG2

1.10e-061881828aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCellTransplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B PIEZO2 SCN3A SNTG2

1.19e-0619018288d6ec2fc0af19a5cb16fff34f8b131b71b33d45f
ToppCellfacs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRAM1 USP9X INSR F8 STRIP2 PIEZO2 ITPRIP ATP1A1

1.29e-0619218281ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A

1.34e-061931828040f6bb42aa41d0921371fdda1cc0912c4fe1930
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 SCN3A

1.34e-061931828e468287c8b30c56d1de65e8347ade233ba6cf584
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RHOBTB3 PPP1R9A LRP1B SORT1 SCN3A ATP1A1 SLC14A2 NLK

1.39e-06194182804bfc555743f7d8821439d05ae442d15e9886c59
ToppCellnucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PLSCR4 ADCY4 SYNM GRIN2B F8 PIEZO2 NR5A2 SNTG2

1.39e-061941828f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RHOBTB3 PPP1R9A LRP1B SORT1 SCN3A ATP1A1 SLC14A2 NLK

1.39e-06194182869bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A RHOBTB3 INSR CLDN7 NCCRP1 STT3B ADRA2A SEL1L3

1.39e-061941828dc531cf9089f2c956621d70d49a2b8219b4b45c1
ToppCellnucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PLSCR4 ADCY4 SYNM GRIN2B F8 PIEZO2 NR5A2 SNTG2

1.39e-0619418283b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCellnucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PLSCR4 ADCY4 SYNM GRIN2B F8 PIEZO2 NR5A2 SNTG2

1.39e-0619418285d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A INSR CLDN7 GALNT7 ADRA2A TMEM184A SEL1L3 ATP1A1

1.45e-0619518282a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A INSR CLDN7 GALNT7 ADRA2A TMEM184A SEL1L3 ATP1A1

1.45e-061951828576142b4e75457c0973051bccc4163bd624496af
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A INSR CLDN7 GALNT7 ADRA2A TMEM184A SEL1L3 ATP1A1

1.45e-0619518288f151066ad3ebd9661ea0b733f03c2ce1518f9ad
ToppCellChildren_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

PLSCR4 ADCY4 TMEM255B F8 PTPRM NR5A2 SNTG2 CFAP161

1.45e-061951828094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

BTBD6 NATD1 WDFY4 STRIP2 PITPNM1 MALRD1 PYGM

1.48e-061361827186be8e1595608004b8216892cb9c7a7f31fbb4d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADCY4 TMEM255B F8 PTPRM NR5A2 ITPRIP ABCG2 CFAP161

1.50e-06196182822767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 NR5A2 SNTG2

1.62e-0619818289ab0db78394e730f6866b2db80047149024ad5f6
ToppCellParenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADCY4 SYNM GRIN2B TMEM255B F8 PIEZO2 NR5A2 SNTG2

1.62e-061981828e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCellBronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

PLSCR4 ADCY4 TMEM255B F8 NR5A2 ITPRIP SNTG2 CFAP161

1.68e-06199182836a230b80096455df26c2e2c8c05fd6b231508c5
ToppCellBronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PLSCR4 ADCY4 SYNM GRIN2B CCDC141 TMEM255B F8 SCN3A

1.75e-062001828e50ef394e3284a8323bfd60575b262b2be422aea
ToppCellBronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PLSCR4 ADCY4 SYNM GRIN2B CCDC141 TMEM255B F8 SCN3A

1.75e-062001828c59f262b2b0a7e7dcb2940d1e466f98db6c56625
ToppCellPBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters

TCAF2 ZNF607 RHOBTB3 LRP8 CERCAM SELENOI ATP1A3

4.37e-0616018274dac64e58d9366c399f3d830848ccb720d400be7
ToppCellEndothelial-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id

PLSCR4 SYNM GRIN2B PLA2R1 PIEZO2 SCN3A DCAF4L1

5.35e-06165182710087d8bd2985906ef19547fe77eb178ae5e1638
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ASPG PLA2R1 CFAP54 CD226 RECQL5 SYVN1 PALLD

6.27e-06169182716c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCellsaliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ASTE1 CCNJ WDFY4 IGHM SCN3A SEL1L3 LAS1L

6.51e-06170182732917888c3f1d54302675c1d4de1fd3b7c79af5f
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HTR1B CWH43 OR2C3 DCSTAMP CCDC141 ATP10A ADRA2B

8.17e-061761827e788c7e0b2bfde31fddbf9e04d07140f8b964857
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLSCR4 ADCY4 F8 CEP68 PIEZO2 SCN3A ANKDD1A

8.80e-061781827ad3de3e03a401dac64431a541899445262246347
ToppCell368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells)

ADCK1 CLDN7 WDFY4 ADRA2B DCAF4L1 TMEM236 GAREM1

8.80e-061781827536a601abcc60867949ea06e9aafb6c7b799b56b
ToppCell5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLSCR4 ADCY4 SYNM PPP1R9A CCDC141 F8 NCCRP1

9.12e-06179182740c65e8623547aeb80f9cd2366e29072467ce069
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADCY4 INSR TMEM255B F8 NR5A2 ABCG2 EPHA4

9.12e-0617918278f9e538c822940785130297712b75131812a4603
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LONRF1 CLEC7A ATP10A RAB44 LRP8 SORT1 MYOF

1.02e-0518218273dec003bad0f3716cf8163861a9d4302a7d6df8c
ToppCellfacs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP9X DDB1 SORT1 PIEZO2 PTPRM ATP1A1 PROS1

1.02e-0518218274c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCellControl-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations)

PLSCR4 ADCY4 TMEM255B NR5A2 ITPRIP SNTG2 ABCG2

1.05e-05183182746be9f96755c7b65aeac061d95d15abeb6466034
ToppCell(6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

PLSCR4 ADCY4 SYNM TMEM255B F8 PIEZO2 SCN3A

1.09e-05184182703ea613e00b45c81b752c14505a0538d698f551e
ToppCellfacs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PPP1R9A CLDN7 CCDC141 TMEM184A ASGR1 SNTG2 SLC4A5

1.09e-05184182703da0f0f89f1ca5a3ccca1e22972f3129464e68e
ToppCellfacs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PPP1R9A CLDN7 CCDC141 TMEM184A ASGR1 SNTG2 SLC4A5

1.09e-05184182761caaa31975e05c9a6512079c791fed5a9e2d39f
ToppCellfacs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PPP1R9A CLDN7 CCDC141 TMEM184A ASGR1 SNTG2 SLC4A5

1.09e-0518418279ed2a65a4ca0ebbbb89ace61027522f93369843d
ToppCellCOVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

ADCY4 TMEM255B F8 PTPRM NR5A2 SNTG2 EPHA4

1.13e-051851827f5e14181f45c37d13ee9e017a4c8bc248c353676
ToppCell3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLSCR4 SYNM TMEM255B F8 PIEZO2 ASGR1 SNTG2

1.17e-051861827eeacf59a9e6bf1c9fd59b6b13d35e8abae228cf0
ToppCell343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells)

PLSCR4 ADCY4 SYNM TMEM255B F8 PIEZO2 SCN3A

1.17e-0518618277a8da2ad140bea3207bd868212cc5e201d586772
ToppCell5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLSCR4 ADCY4 SYNM CCDC141 NCCRP1 ASGR1 HCRTR1

1.17e-0518618279579180db2a0bf3f043b4d169f9a08cdc45b459a
ToppCell343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells)

PLSCR4 ADCY4 SYNM TMEM255B F8 PIEZO2 SCN3A

1.17e-051861827dc394034929c6b10ae0e1c1a028cc3d4ce873298
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLSCR4 ADCY4 CEP68 PIEZO2 SCN3A ANKDD1A ADAMTS20

1.17e-05186182720340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCellCOVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

PLSCR4 ADCY4 TMEM255B F8 PTPRM NR5A2 SNTG2

1.21e-0518718272d20193a6cacdfa4877457c97b0077408942186c
ToppCellwk_20-22-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

ADCY4 SYNM CCDC141 F8 NCCRP1 SCN3A SNTG2

1.21e-05187182755aad84b992412e487a32f4970620189a7380ba6
ToppCelldroplet-Kidney-nan-3m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PLSCR4 ADCY4 DRAM1 F8 PIEZO2 ITPRIP PROS1

1.21e-051871827d72012e94857606f39975cf672f6b8c2e0fe093e
ToppCellCOVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type

PLSCR4 ADCY4 SYNM GRIN2B TMEM255B PIEZO2 SCN3A

1.30e-051891827c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ADCY4 SYNM TMEM255B F8 SCN3A NR5A2 SNTG2

1.30e-05189182755a1776a4ce049959b3f13a43744c7314bc1f00a
ToppCellCF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class

MYCBP2 CCDC141 WDFY4 WDR43 IGHM SCN3A SEL1L3

1.34e-051901827374d8fd63c733178acab07682ed1519693efab45
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations)

ADCY4 TMEM255B F8 PTPRM NR5A2 SNTG2 CFAP161

1.34e-051901827812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RHOBTB3 PPP1R9A LRP1B SORT1 SCN3A SLC14A2 NLK

1.39e-0519118273e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCellwk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ADCY4 SYNM CCDC141 TMEM255B F8 SCN3A SNTG2

1.39e-051911827d25ac3206fe205a100cfee26431ff32c14c1938f
ToppCellrenal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

RHOBTB3 SORT1 PKD2 AKR1B1 SLC14A2 PALLD EPHA4

1.44e-0519218276c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCellHealthy-B_naive|Healthy / disease group, cell group and cell class

KCNH8 RASGRF1 CCDC141 IGHM SCN3A SEL1L3 ZCCHC7

1.44e-0519218275fddf679dcc9c0077d6bfe04c1e602863fb959eb
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM255B F8 PIEZO2 PTPRM NR5A2 ABCG2 CFAP161

1.44e-051921827c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCellCOVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

ADCY4 INSR TMEM255B F8 PTPRM ITPRIP EPHA4

1.44e-05192182727ff3621e177e7932dd44dd6baa81551ea75a874
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TCAF2 ADCY4 TMEM255B PTPRM NR5A2 ITPRIP ABCG2

1.44e-05192182725cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCellfacs-Trachea-nan-3m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLDN7 CCDC141 SORT1 ADRA2B ASGR1 SLC14A2 SLC4A5

1.49e-0519318273038ed3e53d3367136fac5c9773cd5b7414f49d3
ToppCellPCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ADCY4 LONRF1 CCDC141 TMEM255B NR5A2 SEL1L3 CFAP161

1.49e-05193182701c71aa48875b5ad6c50cc810a72862e72f26ad0
ToppCellfacs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLDN7 CCDC141 SORT1 ADRA2B ASGR1 SLC14A2 SLC4A5

1.49e-051931827f73630725f093c646bdaf178c39505c04a16e2c6
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

TMEM255B F8 PIEZO2 PTPRM NR5A2 ABCG2 CFAP161

1.49e-05193182752e918884877b6659cdca0496390e440f73694a9
ToppCellfacs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLDN7 CCDC141 SORT1 ADRA2B ASGR1 SLC14A2 SLC4A5

1.49e-051931827c5925b3b5d19098e3987789d68a493d7fd548ac9
ToppCellfacs-Trachea-3m-Epithelial-glandular_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLDN7 CCDC141 SORT1 ADRA2B ASGR1 SLC14A2 SLC4A5

1.49e-0519318276905de261d90dfe3dd2c2cf5b2e26afb2bcc3d5b
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A RHOBTB3 INSR CLDN7 NCCRP1 STT3B SEL1L3

1.54e-051941827855d6acfcf323868ba98b213f06186ad4793d4ed
ToppCell5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLSCR4 ADCY4 SYNM TMEM255B F8 PIEZO2 ASGR1

1.54e-051941827937ee85ffd50869b60f0f6e91017ab77e8b24c0b
ToppCellRV-09._Endothelium_I|RV / Chamber and Cluster_Paper

ADCY4 F8 PTPRM NR5A2 SNTG2 CFAP161 EPHA4

1.54e-0519418277b408096e717f2327c12aea35a8d5fc4621d3b06
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A RHOBTB3 INSR CLDN7 NCCRP1 STT3B SEL1L3

1.54e-05194182729a7770bdbea6081a9ed64a997cd92a1cbf4af58
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A RHOBTB3 INSR CLDN7 NCCRP1 STT3B SEL1L3

1.54e-051941827ca051088f880154ae2fd3f0ab3cef5a8dba8c371
ToppCellIPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class

PPP1R9A GRIN2B CCDC141 ATP10A PIEZO2 SCN3A IGSF3

1.59e-051951827de88e9d22044b4b3e29676ad02b3e9299cc920ad
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PLSCR4 ADCY4 SYNM TMEM255B F8 PIEZO2 ASGR1

1.59e-05195182736d4a11bc77a4cc97a22525c78ef8359f4a3ca66
ToppCellAT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id

RASGRF1 DRAM1 CLDN7 TMEM178A ATP1A1 IGSF3 GAREM1

1.59e-051951827bb45a17871a8a2593bc16a95f22e3c239c49985b
ToppCellfacs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM45A RHOBTB3 LAMA2 PKD2 CERCAM CHPF PROS1

1.59e-051951827223f5f07dc28fa13a09bb589884c58043c7928c7
ToppCellfacs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DRAM1 INSR F8 PIEZO2 ITPRIP ABCG2 ATP1A1

1.59e-0519518273969b8d5fcec8ef1831531a781f7bbcebab5a4ba
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

RHOBTB3 PPP1R9A SORT1 SCN3A ATP1A1 SLC14A2 NLK

1.64e-051961827c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

FAM180B LAMA2 ATP10A PIEZO2 CERCAM PALLD IGSF3

1.64e-05196182724d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCelldroplet-Tongue-nan-3m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPPK1 ASPG DCT NCCRP1 SORT1 PALLD EPHA4

1.64e-051961827159061fd0961b2cfb5941d403acc5b395dd0d3a0
ToppCellBronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

TMEM45A PPP1R9A INSR CLDN7 GALNT7 ADRA2A SEL1L3

1.64e-051961827057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCellfacs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RHOBTB3 DDB1 STT3B IGF2R SEC23IP PKD2 CERCAM

1.64e-051961827c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8
ToppCellfacs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RHOBTB3 DDB1 STT3B IGF2R SEC23IP PKD2 CERCAM

1.64e-05196182744f5b1b474399c9316729155f2ea95a82ca66e30
ToppCell3'-Distal_airway-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TMEM45A ASPG INSR GALNT7 ADRA2A TMEM184A SEL1L3

1.64e-0519618278e909c31733762646359fe78b645cbd60237459e
DrugL-DOPA methyl ester

HTR1B MAOB DCT TYR ADRA2A ADRA2B

1.86e-09161836CID000023497
DrugYohimbine

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

7.75e-09101835DB01392
DrugOlanzapine

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

3.87e-08251836DB00334
DrugZiprasidone

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

3.87e-08251836DB00246
DrugAripiprazole

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

3.87e-08251836DB01238
DrugClozapine

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

5.00e-08261836DB00363
DrugQuetiapine

HTR1A HTR1B HTR1E ADRA2A ADRA2B ADRA2C

5.00e-08261836DB01224
DrugLisuride

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

6.00e-08141835DB00589
DrugPramipexole

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

6.00e-08141835DB00413
DrugRopinirole

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

6.00e-08141835DB00268
DrugCabergoline

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

8.93e-08151835DB00248
DrugApomorphine

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

8.93e-08151835DB00714
DrugPergolide

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

1.82e-07171835DB01186
Drugnaftopidil

HTR1A SYNM F2 ADRA2A ADRA2B

1.82e-07171835CID000004418
Drugfenfluramine

HTR1A HTR1B HTR1E MAOB SYNM INSR DCT BIRC6 ADRA2A ADRA2B SCN3A

2.17e-0717818311CID000003337
DrugBromocriptine

HTR1A HTR1B ADRA2A ADRA2B ADRA2C

2.50e-07181835DB01200
DrugS 14489

HTR1A HTR1B ADRA2A ADRA2B

2.76e-0781834CID000182595
DrugS 15931

HTR1A HTR1B ADRA2A ADRA2B

4.93e-0791834CID000182596
DrugClonidine

ADRA2A ADRA2B ADRA2C

5.11e-0731833DB00575
DrugBrimonidine

ADRA2A ADRA2B ADRA2C

5.11e-0731833DB00484
DrugTizanidine

ADRA2A ADRA2B ADRA2C

5.11e-0731833DB00697
DrugMethamphetamine

MAOB ADRA2A ADRA2B ADRA2C

8.17e-07101834DB01577
DrugS 14671

HTR1A HTR1B ADRA2A ADRA2B

8.17e-07101834CID000131907
Drugazapetine

HTR1B ADRA2A ADRA2B AKR1B1

8.17e-07101834CID000008966
DrugS-(-)-Lisuride

ADCY4 HTR1A HTR1B HTR1E MAOB ADRA2A ADRA2B

9.08e-07651837CID000003938
Drugpiribedil

HTR1A HTR1B ADRA2A ADRA2B MAPK7 NLK

1.02e-06421836CID000004850
DrugAC1Q6F2A

HTR1A HTR1B ADRA2A ADRA2B

1.28e-06111834CID000060621
DrugEphedra

MAOB ADRA2A ADRA2B ADRA2C

1.90e-06121834DB01363
DrugBethanidine

ADRA2A ADRA2B ADRA2C

2.03e-0641833DB00217
Drug2-methoxyidazoxan

ADRA2A ADRA2B ADRA2C

2.03e-0641833ctd:C058525
DrugNSC169490

HTR1A HTR1B HTR1E ADRA2A ADRA2B

2.22e-06271835CID004210613
Drugbetaxolol

ADCY4 HTR1A HTR1B ADRA2A ADRA2B MAPK7

2.30e-06481836CID000002369
Drugbutoxamine

ADCY4 HTR1A HTR1B ADRA2A ADRA2B

2.69e-06281835CID000018026
Drugmethiothepin

ADCY4 HTR1A HTR1B HTR1E MAOB ADRA2A ADRA2B

2.89e-06771837CID000004106
Drugbuspirone

ADCY4 HTR1A HTR1B HTR1E MAOB ADRA2A ADRA2B

3.74e-06801837CID000002477
DrugFMMT

HTR1A HTR1B MAOB MYBPC3

3.80e-06141834CID006438682
DrugMK-912

HTR1A HTR1B ADRA2A ADRA2B

3.80e-06141834CID000123679
DrugSDZ 216-525

HTR1A HTR1B ADRA2A ADRA2B

3.80e-06141834CID003037456
DrugRisperidone

HTR1A ADRA2A ADRA2B ADRA2C

3.80e-06141834DB00734
DrugAC1L1G8Z

HTR1A HTR1B HTR1E ADRA2A ADRA2B

3.84e-06301835CID000003581
DrugGuaifenesin [93-14-1]; Up 200; 20.2uM; HL60; HT_HG-U133A

HTR1E GRIN2B MYOF ADRA2C CNGB3 ABCG2 ATP1A3 CHPF NLK CYB561

4.42e-06196183102569_UP
DrugVerteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A

INSR GALNT7 TMX1 CEP68 MFAP3 IGF2R FZD5 IGSF3 EPHA4

4.72e-0615518396817_DN
DrugFenoldopam

ADRA2A ADRA2B ADRA2C

5.05e-0651833DB00800
Drugiodocyanopindolol

ADCY4 HTR1A HTR1B ADRA2A ADRA2B

6.28e-06331835CID000068618
DrugMHPG

HTR1A HTR1B MAOB SYNM ADRA2A ADRA2B

6.41e-06571836CID000010805
Drugcyanopindolol

ADCY4 HTR1A HTR1B HTR1E ADRA2A ADRA2B

6.41e-06571836CID000155346
Drugmianserin

ADCY4 HTR1A HTR1B HTR1E MAOB ADRA2A ADRA2B

6.57e-06871837CID000004184
Drugfluparoxan

HTR1A HTR1B ADRA2A ADRA2B

6.82e-06161834CID000072036
Drugtransdihydrolisuride

HTR1A HTR1B RASGRF1 ADRA2A ADRA2B

7.31e-06341835CID000005406
Drugfluspirilene

HTR1A HTR1B HTR1E ADRA2A ADRA2B

7.31e-06341835CID000003396
Drugidazoxan

HTR1A HTR1B HTR1E MAOB ADRA2A ADRA2B PYGM

7.64e-06891837CID000054459
DrugPaliperidone

HTR1A ADRA2A ADRA2B ADRA2C

8.86e-06171834DB01267
Drugimiloxan

HTR1A HTR1B ADRA2A ADRA2B

8.86e-06171834CID000133621
DrugS 15535

HTR1A HTR1B ADRA2A ADRA2B

8.86e-06171834CID000132787
Drugipsapirone

ADCY4 HTR1A HTR1B HTR1E ADRA2A ADRA2B

9.56e-06611836CID000056971
Drugmolindone

HTR1A HTR1B MAOB ADRA2A ADRA2B

9.78e-06361835CID000023897
DrugPhenoxybenzamine

ADRA2A ADRA2B ADRA2C

1.00e-0561833DB00925
Drug7-hydroxychlorpromazine

TYR ADRA2A ADRA2B

1.00e-0561833CID000016414
DrugXylometazoline

ADRA2A ADRA2B ADRA2C

1.00e-0561833DB06694
Drugmoclobemide

HTR1A HTR1B MAOB TYR ADRA2A ADRA2B

1.05e-05621836CID000004235
Drugtyramine

ADCY4 HTR1A HTR1B MAOB TYR ADRA2A ADRA2B CYB561

1.05e-051301838CID000005610
Drugserotonin

ADCY4 HTR1A HTR1B HTR1E MAOB F2 TYR ADRA2A ADRA2B AKR1B10 ATP1A1 ATP1A3 MAPK7 HPS5 GPR176 NLK

1.11e-0555418316CID000005202
DrugCAS 66104-23-2

ADCY4 HTR1A HTR1B MAOB ADRA2A ADRA2B

1.15e-05631836CID000004745
Drugpindolol

ADCY4 HTR1A HTR1B HTR1E ADRA2A ADRA2B

1.15e-05631836CID000004828
DrugRo 41-9067

ADCY4 HTR1B ADRA2A ADRA2B

1.42e-05191834CID000125800
Drugbenalfocin

HTR1A HTR1B ADRA2A ADRA2B

1.42e-05191834CID000123981
Drugalpha-methyl-p-tyrosine

HTR1A HTR1B MAOB TYR ADRA2A ADRA2B

1.51e-05661836CID000003125
DrugL-adrenaline

PRSS2 ADCY4 MAOB INSR GRIN2B F2 ADRA2A ADRA2B PYGM C4A ATP1A1 ATP1A3 MAPK7 AKR1B1

1.61e-0544618314CID000000838
DrugRX821002

HTR1A HTR1B MAOB ADRA2A ADRA2B

1.66e-05401835CID000108094
DrugNSC95090

HTR1A HTR1B HTR1E ADRA2A ADRA2B

1.66e-05401835CID000003251
DrugLurasidone Hydrochloride

HTR1A ADRA2A ADRA2C

1.75e-0571833ctd:D000069056
DrugEletriptan

HTR1A HTR1B HTR1E

1.75e-0571833DB00216
Drugxylometazoline

ADRA2A ADRA2B ADRA2C

1.75e-0571833ctd:C009695
DrugICI 169,369

HTR1A HTR1B ADRA2A ADRA2B

1.77e-05201834CID000122265
DrugDoxepin

HTR1A ADRA2A ADRA2B ADRA2C

1.77e-05201834DB01142
DrugSaphris

HTR1A HTR1B HTR1E ADRA2A ADRA2B

1.88e-05411835CID000163091
DrugEEDQ

ADCY4 HTR1A HTR1B HTR1E ADRA2A ADRA2B

2.50e-05721836CID000027833
Drugmedifoxamine

HTR1A HTR1B HTR1E

2.78e-0581833CID000036109
DrugOxymetazoline

ADRA2A ADRA2B ADRA2C

2.78e-0581833ctd:D010109
DrugNRA 0045

HTR1A ADRA2A ADRA2B

2.78e-0581833ctd:C106996
Drugoctopamine

ADCY4 HTR1A MAOB TYR ADRA2A ADRA2B PYGM

2.89e-051091837CID000004581
Drugcirazoline

HTR1A HTR1B MAOB ADRA2A ADRA2B

2.99e-05451835CID000002765
Drugloxapine

HTR1A HTR1B HTR1E ADRA2A ADRA2B

3.33e-05461835CID000003964
DrugChlorambucil [305-03-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A

PLSCR4 RASGRF1 LAMA2 IL1RL2 PPP2R1B CNGB3 ADAMTS20 MAPK7 SLC14A2

3.35e-0519818394345_UP
Drugsodium 4-phenylbutyrate; Up 200; 1000uM; PC3; HG-U133A

HTR1B RASGRF1 CYP26A1 DCSTAMP ATP10A PPP2R1B PTPRN CD101 NR5A2

3.35e-051981839434_UP
Drugbeta-hydroxyaspartic acid

GRIN2B F2 STT3B C4A PROS1

3.71e-05471835CID000005425
DrugB-HT 920

HTR1A HTR1B MAOB ADRA2A ADRA2B

3.71e-05471835CID000005374
DrugErgot

HTR1A HTR1B HTR1E ADRA2A ADRA2B

4.11e-05481835CID000003250
DrugNeomigran

ADCY4 HTR1A HTR1B ADRA2A ADRA2B

4.11e-05481835CID000003066
DrugPhenyl-P

F8 ADRA2A ADRA2B

4.14e-0591833CID006454947
Drugphenethylamine

MAOB ADRA2A ADRA2C

4.14e-0591833ctd:C029261
DrugAC1NUHTW

ADRA2A ADRA2B IGF2R

4.14e-0591833CID005479139
Drugoxymetazoline

ADCY4 HTR1A HTR1B HTR1E ADRA2A ADRA2B

4.24e-05791836CID000004636
DrugSCH 23390

ADCY4 HTR1A HTR1B HTR1E GRIN2B ADRA2A ADRA2B

4.31e-051161837CID000005018
Drugguanfacine

HTR1A HTR1B ADRA2A ADRA2B

4.48e-05251834CID000003519
DrugBRL 44408

HTR1A HTR1B ADRA2A ADRA2B

4.48e-05251834CID000121850
Drugzotepine

HTR1A HTR1B HTR1E ADRA2A ADRA2B

4.55e-05491835CID000005736
Drug8-OH-DPAT

ADCY4 HTR1A HTR1B HTR1E GRIN2B ADRA2A ADRA2B

4.55e-051171837CID000001220
Drugsumatriptan

ADCY4 HTR1A HTR1B HTR1E MAOB GNPTAB

4.56e-05801836CID000005358
DrugNSC186061

ADCY4 HTR1A HTR1B HTR1E MAOB ADRA2A ADRA2B

4.81e-051181837CID000004163
Diseaseanxiety disorder (implicated_via_orthology)

HTR1A HTR1B ADRA2A SCN3A

8.23e-06221764DOID:2030 (implicated_via_orthology)
Diseasegeneralized anxiety disorder (implicated_via_orthology)

HTR1A HTR1B HTR1E

1.14e-0581763DOID:14320 (implicated_via_orthology)
DiseaseAutistic Disorder

HTR1B MAOB CHD8 GRIN2B WDFY4 ATP10A JMJD1C SNTG2 C4B

2.90e-052611769C0004352
Diseasehyperhomocysteinemia (implicated_via_orthology)

GRIN2B F2 F8

3.32e-05111763DOID:9279 (implicated_via_orthology)
DiseaseEndometrioma

MAOB CYP26A1 DCSTAMP CD226 CCNE2 NR5A1 AKR1B1

5.37e-051611767C0269102
DiseaseEndometriosis

MAOB CYP26A1 DCSTAMP CD226 CCNE2 NR5A1 AKR1B1

5.37e-051611767C0014175
Diseasehereditary spastic paraplegia 28 (implicated_via_orthology)

SEC23IP DDHD2

1.06e-0431762DOID:0110779 (implicated_via_orthology)
Diseasehereditary spastic paraplegia 54 (implicated_via_orthology)

SEC23IP DDHD2

1.06e-0431762DOID:0110806 (implicated_via_orthology)
Diseasegout, hyperuricemia

MALRD1 PKD2 ABCG2

1.10e-04161763EFO_0004274, EFO_0009104
DiseaseMental Depression

HTR1A HTR1B MAOB GRIN2B CSMD2 ADRA2A ATP1A3 HCRTR1

1.51e-042541768C0011570
Diseaseoculocutaneous albinism (is_implicated_in)

DCT TYR

2.11e-0441762DOID:0050632 (is_implicated_in)
Diseasecolor blindness (is_implicated_in)

CNGB3 CNGA3

2.11e-0441762DOID:13399 (is_implicated_in)
Diseasealdose reductase measurement

AKR1B10 AKR1B1

2.11e-0441762EFO_0801364
DiseaseHypotension

HTR1B MAOB GRIN2B ADRA2A

2.85e-04531764C0020649
Diseaseuric acid measurement

USP34 INSR BIRC6 MYOF SIMC1 NR5A2 PKD2 PYGM ABCG2 AKR1B1 SLC14A2 GAREM1

3.19e-0461017612EFO_0004761
DiseaseMonochromatopsia

CNGB3 CNGA3

3.50e-0451762C0751043
DiseaseColor Blindness, Inherited

CNGB3 CNGA3

3.50e-0451762C0751042
DiseaseColor blindness

CNGB3 CNGA3

3.50e-0451762C0242225
DiseaseColor vision defect

CNGB3 CNGA3

3.50e-0451762C0009398
Diseaseoculocutaneous albinism (implicated_via_orthology)

DCT TYR

3.50e-0451762DOID:0050632 (implicated_via_orthology)
DiseaseColor Blindness, Red

CNGB3 CNGA3

3.50e-0451762C0155015
DiseaseColor Blindness, Red-Green

CNGB3 CNGA3

3.50e-0451762C0155016
DiseaseColor Blindness, Acquired

CNGB3 CNGA3

3.50e-0451762C0155018
DiseaseAchromatopsia

CNGB3 CNGA3

3.50e-0451762cv:C0152200
DiseaseColor Blindness, Green

CNGB3 CNGA3

3.50e-0451762C0239777
DiseaseDepressive disorder

HTR1A HTR1B MAOB GRIN2B CSMD2 ADRA2A ATP1A3 HCRTR1

3.62e-042891768C0011581
Diseasevisuospatial function measurement

GRIN2B WRAP73 GPR176

4.90e-04261763EFO_0803533
DiseaseVACTERL association (implicated_via_orthology)

IFT172 TBC1D32

5.22e-0461762DOID:14679 (implicated_via_orthology)
DiseaseColor Blindness, Blue

CNGB3 CNGA3

5.22e-0461762C0155017
DiseaseMood Disorders

HTR1A HTR1B MAOB ADRA2A ADRA2C HCRTR1

5.32e-041681766C0525045
Diseasemetabolite measurement

ASPG CYP26A1 INSR WDFY4 CYP4Z2P MYOF IGF2R AKR1B10 NR5A2 ABCG2 HPS5

5.72e-0456017611EFO_0004725
DiseaseAchromatopsia

CNGB3 CNGA3

7.28e-0471762C0152200
Diseasefamilial hemiplegic migraine (implicated_via_orthology)

ATP1A1 ATP1A3

7.28e-0471762DOID:0060178 (implicated_via_orthology)
DiseaseThrombophilia due to thrombin defect

F2 PROS1

9.67e-0481762cv:C3160733
Diseasepimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement

CYP4Z2P IGF2R

9.67e-0481762EFO_0800494
Diseaseurate measurement

USP34 INSR BIRC6 JMJD1C STT3B PPP2R1B MALRD1 PKD2 PYGM NR5A1 ABCG2 DDHD2 SLC14A2 EPHA4

1.00e-0389517614EFO_0004531
Diseaserefractive error, self reported educational attainment

RASGRF1 LAMA2 SLC14A2

1.09e-03341763EFO_0004784, MONDO_0004892
DiseaseOsteitis Deformans

DCSTAMP NUP205

1.24e-0391762C0029401
Diseasewhite matter growth measurement

AKR1B10 AKR1B1

1.24e-0391762EFO_0009335
DiseaseThrombophilia

F2 F8

1.24e-0391762C0398623
Diseasevery low density lipoprotein particle size measurement

CYP26A1 INSR DCT JMJD1C ASGR1

1.24e-031331765EFO_0008594
Diseasecups of coffee per day measurement

ABCG2 ATP1A1 ATP1A3

1.75e-03401763EFO_0006782
DiseaseJeune thoracic dystrophy

IFT172 IFT80

1.88e-03111762C0265275
Diseasefactor VIII deficiency (is_implicated_in)

F2 F8

1.88e-03111762DOID:12134 (is_implicated_in)
DiseaseTakayasu arteritis

MSH5 LRP1B TRANK1 SLC14A2 ABHD16A

1.98e-031481765EFO_1001857
Diseasenervous system disease (implicated_via_orthology)

ATP1A1 ATP1A3

2.24e-03121762DOID:863 (implicated_via_orthology)
DiseaseCongenital muscular dystrophy

LAMA2 POMGNT1

2.24e-03121762cv:C0699743
DiseaseThromboembolism

F2 PROS1

2.24e-03121762C0040038
Diseaseleft ventricular systolic function measurement

CCDC141 LRP1B GAREM1

2.31e-03441763EFO_0008206
Diseasecoffee consumption measurement, tea consumption measurement

CYP26A1 JMJD1C ABCG2

2.31e-03441763EFO_0006781, EFO_0010091
DiseaseBipolar Disorder

HTR1A HTR1B MAOB RASGRF1 GRIN2B ADRA2C TRANK1 ATP1A1 ATP1A3

2.36e-034771769C0005586
Diseaseplatelet aggregation

CSMD2 JMJD1C ADRA2A

2.46e-03451763GO_0070527
Diseaseosteitis deformans

DCSTAMP NUP205

2.64e-03131762EFO_0004261
DiseaseConnective Tissue Diseases

PIEZO2 PKD2

2.64e-03131762C0009782
DiseaseAcute Confusional Senile Dementia

MAOB INSR F2 IGF2R

2.96e-03991764C0546126
DiseaseAlzheimer's Disease, Focal Onset

MAOB INSR F2 IGF2R

2.96e-03991764C0750900
DiseaseAlzheimer Disease, Early Onset

MAOB INSR F2 IGF2R

2.96e-03991764C0750901
DiseasePresenile dementia

MAOB INSR F2 IGF2R

2.96e-03991764C0011265
DiseaseAlzheimer Disease, Late Onset

MAOB INSR F2 IGF2R

2.96e-03991764C0494463
Diseaseepilepsy (implicated_via_orthology)

GRIN2B LRP1B SCN3A ATP1A1 ATP1A3

3.01e-031631765DOID:1826 (implicated_via_orthology)
Diseasediabetic neuropathy (is_implicated_in)

ADRA2B AKR1B1

3.07e-03141762DOID:9743 (is_implicated_in)
Diseasepolycystic kidney disease (implicated_via_orthology)

IFT172 PKD2

3.07e-03141762DOID:0080322 (implicated_via_orthology)
Diseasediabetic neuropathy (implicated_via_orthology)

INSR AKR1B1

3.07e-03141762DOID:9743 (implicated_via_orthology)
DiseaseFamilial Alzheimer Disease (FAD)

MAOB INSR F2 IGF2R

3.07e-031001764C0276496
DiseaseAlzheimer's Disease

MAOB INSR F2 IGF2R

3.19e-031011764C0002395
Diseasesitting height ratio

PTPRM PKD2 ABCG2

3.52e-03511763EFO_0007118
DiseaseMyopia

RASGRF1 LAMA2

3.53e-03151762C0027092
Diseasetype 2 diabetes mellitus (is_implicated_in)

INSR ADRA2A ADRA2B IGF2R AKR1B1

3.70e-031711765DOID:9352 (is_implicated_in)
Diseasediabetic retinopathy (implicated_via_orthology)

INSR AKR1B1

4.02e-03161762DOID:8947 (implicated_via_orthology)
DiseaseAgents acting on the renin-angiotensin system use measurement

CYP26A1 INSR CEP68 AKR1B10 ZCCHC7 CYB561 MYBPC3

4.11e-033351767EFO_0009931
Diseasereticulocyte count

USP34 NATD1 USP9X RHOBTB3 INSR BIRC6 JMJD1C PTPRN CD226 LTN1 C4B AKR1B1 DCAF4 HCRTR1

4.12e-03104517614EFO_0007986
Diseasepulse pressure measurement

USP34 INSR MSH5 CCDC141 CEP68 PIEZO2 ADRA2B TRANK1 MALRD1 ANKDD1A SULT6B1 CERCAM IFT80 DDHD2 SLC14A2 PALLD MYBPC3

4.14e-03139217617EFO_0005763
Diseasemuscular dystrophy (is_implicated_in)

LAMA2 POMGNT1

4.54e-03171762DOID:9884 (is_implicated_in)
Diseasecyclic adenosine monophosphate measurement

PTPRM ABCG2

4.54e-03171762EFO_0010473
Diseasealpha-L-iduronidase measurement

DRAM1 GNPTAB

4.54e-03171762EFO_0020139
Diseaselifestyle measurement, alcohol consumption measurement

CSMD2 NUP205 CFAP54 PIEZO2

5.06e-031151764EFO_0007878, EFO_0010724
Diseaseleft ventricular mass

CCDC141 MYBPC3

5.08e-03181762EFO_0009289
Diseaseforced expiratory volume, response to bronchodilator

HTR1A EPPK1 DCT LRP1B NUP205 PIEZO2 SNTG2 HCRTR1

5.43e-034451768EFO_0004314, GO_0097366
DiseaseAlcoholic Intoxication, Chronic

HTR1A HTR1B MAOB GRIN2B LRP8 ADRA2A

5.57e-032681766C0001973
DiseaseIntellectual Disability

CHD8 GRIN2B STT3B ADRA2B SCN3A TFB2M ATP1A1 LAS1L

5.57e-034471768C3714756
DiseaseCongenital hernia of foramen of Morgagni

INSR IGF2R

5.66e-03191762C0265699
DiseaseCongenital hernia of foramen of Bochdalek

INSR IGF2R

5.66e-03191762C0265700

Protein segments in the cluster

PeptideGeneStartEntry
AWLVDHVYAIREAAT

PPP2R1B

461

P30154
YCRLEDAHLVVVTSW

ASGR1

181

P07306
HDTTTTAISWIFYCL

CYP4Z2P

316

Q8N1L4
AVGQDCYTRIWSLHD

DCAF4

431

Q8WV16
SILHLCVIALDRYWA

HTR1B

136

P28222
CVIALDRYWAITDAV

HTR1B

141

P28222
TEEFRLNYCHLWQSL

ADCK1

346

Q86TW2
EEWSLFESSAVHLIY

CFAP54

496

Q96N23
SYLHCEWATISQLEK

CHD8

676

Q9HCK8
ATRCIHLETQVWAAY

ERVK11-1

36

P61568
CVAAILWHSYELLVE

BIRC6

3496

Q9NR09
EYHNNADCTWTILAE

CSMD2

221

Q7Z408
ELICWLYNVADVTDH

CEP68

636

Q76N32
VIALDALSAYWIASH

C4B

1306

P0C0L5
ALSAYWIASHTTEER

C4B

1311

P0C0L5
WIEICHYIATCVFLG

TBC1D32

1171

Q96NH3
NDNCWLSVETHLLYI

CALCR

286

P30988
LTLEETHSIFLWYTA

BTBD6

356

Q96KE9
HLCAISLDRYWSVTQ

ADRA2C

141

P18825
VEEDWCLSVLRSYQA

ABHD16A

491

O95870
EISYTTSFCHQLRWV

ABCG2

366

Q9UNQ0
LHLCVIALDRYWAIT

HTR1E

111

P28566
LDWLLEVCEVYTLHR

CCNE2

146

O96020
LHRLTAYSWDFLVQC

CCNJ

216

Q5T5M9
WRACNVLQSSHLEDY

AKR1B10

296

O60218
VHLCAISLDRYWAVS

ADRA2B

101

P18089
SHAWLSECLIVRLYL

ADCY4

761

Q8NFM4
VYLTDEVSHVNCWQA

CFAP161

181

Q6P656
TSVYLATLHENDLWF

DPY19L3

61

Q6ZPD9
DLYSLHSWCGILVFV

CYB561

116

P49447
IAVSCYWLQHTETKA

ASTE1

466

Q2TB18
EEYACWLQSHLEAES

ATP10A

821

O60312
LYHLSLFITRSWEVD

ADAMTS20

11

P59510
EELFIVSKLWCTYHE

AKR1B1

71

P15121
WVDIAHLCLYNLSVI

MTF2

266

Q9Y483
TSQESFAHVRYWLDC

RAB44

916

Q7Z6P3
VYLSHTAWTEACQVE

INTS4

896

Q96HW7
SSTDWLLSFAVYERH

ITPRIP

376

Q8IWB1
IIETCLFILWRHLEY

NUP205

1896

Q92621
LYTLTTIEDCWLHVN

LTN1

321

O94822
TVHYALLSASWAVLC

ANO7

166

Q6IWH7
LCVTAETHEVSALWF

MAOB

171

P27338
VYHVVSAICEWTVAF

DRAM1

196

Q8N682
LHEYTQAIDLWSVGC

MAPK7

236

Q13164
RWVEYFCLAEGHVAS

FBXW9

161

Q5XUX1
SEHIWCEDFLVRSFY

PTPRN

841

Q16849
ADRLSLIYSWHAITD

LRP1B

3246

Q9NZR2
DVTWRYSCKHEEVIA

NGLY1

386

Q96IV0
VLEWSRDQYHVLFDS

GNPTAB

41

Q3T906
TCTEVWSNSLGHLVY

GPR176

191

Q14439
AEWVCLAQTIKRHYE

ASPG

91

Q86U10
RELHDLVYSQACSWF

LONRF1

681

Q17RB8
WTYEQRKIVEFTCHT

ATP1A1

906

P05023
EDFSTFLVEYHLIWA

JMJD1C

76

Q15652
HCVLTWTERGIYIFI

HPS5

301

Q9UPZ3
AVGQDCYTRIWSLHD

DCAF4L1

331

Q3SXM0
TDLLAHTNYTFEIWA

EPHA4

401

P54764
DSRLDACVYELHVWL

NCCRP1

186

Q6ZVX7
ACVYELHVWLLAADR

NCCRP1

191

Q6ZVX7
FVAEHWNLCRAVYSI

PLSCR4

221

Q9NRQ2
LWSYEEDSHCLHIQS

PLXNB3

516

Q9ULL4
GLEYVHSWLSILFCL

OR51L1

21

Q8NGJ5
HSWLSILFCLAYLVA

OR51L1

26

Q8NGJ5
LIYWTSLLDVGCISH

OR3A4P

291

P47883
LIHLCIWVLFAAVDY

DCSTAMP

301

Q9H295
DYLLIHSCRQWTTIT

GAREM1

51

Q9H706
FALQSHLCYWESEDT

DDHD2

676

O94830
HLCYWESEDTVLLVL

DDHD2

681

O94830
TWEDIAFHISLYRDT

DNAH12

836

Q6ZR08
WDQVTVYLFCDDHKL

LAS1L

51

Q9Y4W2
WQYHAVTDTECLTLY

LAMA2

166

P24043
LSVCLHEVAYWYILS

F8

646

P00451
FCWGLLEELVTVAHY

MROH6

561

A6NGR9
ELCYLATIDWSRILD

INSR

151

P06213
RHYSNAIDIWSVGCI

NLK

316

Q9UBE8
QFYISHWLGATECVL

OR2C3

101

Q8N628
VVEEDLKAHLTCWYI

NATD1

81

Q8N6N6
IECLLTASHYEDVHW

MFAP3

71

P55082
CAEAYHSWADLRDVL

IFT172

1496

Q9UG01
IVSCTARLDVYTQWH

PALLD

1316

Q8WX93
IDIVLWYRSAFHSTE

IL1RL2

361

Q9HB29
QRSFIALDHLWVYAC

MALRD1

411

Q5VYJ5
TLSFIALDRWYAICH

HCRTR1

136

O43613
EQHYRESWEAALTCA

FZD5

471

Q13467
YHCAVEEWLLSTNGT

CD101

776

Q93033
YRTEGSHITIWCNVS

IGSF3

31

O75054
EELYSCSDDHQIVKW

IFT80

26

Q9P2H3
KWTAHDVENRIECLY

KLHL23

206

Q8NBE8
AVVLLVYHWSSRESE

BFAR

156

Q9NZS9
ISLELFICQYHIWLA

CASD1

706

Q96PB1
CHFWYEDASATVVRV

CCDC141

1021

Q6ZP82
RYFAHSILTVSEEEW

IGHM

391

P01871
AVIWEHDYTSVCLKL

ARV1

196

Q9H2C2
VLIYLDAHCEVAVNW

GALNT7

296

Q86SF2
HLCAIALDRYWAITD

HTR1A

126

P08908
EVCDAWSLTHSERYA

ELMO3

36

Q96BJ8
LWFTVLEHYHRTSCI

MYBPHL

191

A2RUH7
WTYEQRKVVEFTCHT

ATP1A3

896

P13637
LTAGWDELECHRVYN

FBXO47

171

Q5MNV8
LASVILKQYVETHWC

IPO9

76

Q96P70
HGLDSWSCVYFVVTV

SELENOI

126

Q9C0D9
GWNVIYSICDTHDVA

CYP26A1

391

O43174
TLIDSWCKDHSYVIA

EMC8

76

O43402
LHVYRALCEEVLWHT

CD226

11

Q15762
CFLSHYSIWEEVVAR

CERCAM

391

Q5T4B2
YEWTTEKELRTECNH

DDB1

891

Q16531
VIALDALSAYWIASH

C4A

1306

P0C0L4
ALSAYWIASHTTEER

C4A

1311

P0C0L4
DVEVATNRIYWCDLS

LRP8

456

Q14114
NTVKDFWRLVLDYHC

PTPRM

1266

P28827
DCLSTWLLHFIATNY

RHOBTB3

546

O94955
ELAEIHLCVLWNSGY

MSH5

46

O43196
WVDVAHLVLYHLSVC

PHF1

251

O43189
WDFEHLLLTGLSCVY

FAM180B

116

Q6P0A1
CWSELLILDHIYRQV

NR5A2

381

O00482
ESLLGCVSWSLYHDL

CWH43

11

Q9H720
ATECVHYFEWRTTAA

IGF2R

146

P11717
HLLERSWYAVTETCL

SYVN1

76

Q86TM6
SASDWYDALCILLRH

USP9X

2066

Q93008
NCEEKDYTIWLAHST

SORT1

611

Q99523
CWSELLVFDHIYRQV

NR5A1

301

Q13285
CGSNWILHIVSELIY

SULT6B1

66

Q6IMI4
SLISEQWVVSAGHCY

PRSS3P2

51

Q8NHM4
LLFWIYSSCIEDSHR

TMEM179B

81

Q7Z7N9
ILQELYERCWSHSNE

SEL1L3

1021

Q68CR1
ECDSEVDVLHWSRYN

STRIP2

141

Q9ULQ0
REVHDSYALLVAESW

SYNM

181

O15061
CQDVLHLYRLLWASA

TMEM255B

186

Q8WV15
EATCNLWSVYVHETV

TCAF2

776

A6NFQ2
LEGEVTHWLACSLYV

RBL1

51

P28749
VVDHTITSCEWVDFY

PIWIL2

876

Q8TC59
ITSCEWVDFYLLAHH

PIWIL2

881

Q8TC59
LLVTAIFTDHWYETD

TMEM178A

21

Q8NBL3
IFVWTALVLTCHQIY

TMEM184A

61

Q6ZMB5
HLLEEDDSLYCISAW

POMGNT1

411

Q8WZA1
VWDVLFSSYLSEAHR

EPPK1

4791

P58107
VAHVVSENWSKDYCI

SPPL2C

26

Q8IUH8
WDELVEHLQFLLSSY

SIMC1

766

Q8NDZ2
LYHVLSVIWQLACEI

TFB2M

246

Q9H5Q4
SVECFESLLSILHWS

MYCBP2

1416

O75592
SIFVCSDWQLLRHFD

WRAP73

161

Q9P2S5
RKTCYSIVEHNWFET

SCN3A

1196

Q9NY46
WVRAERTYHLCEVLF

SNTG2

341

Q9NY99
ALQSHLCYWESEDTA

SEC23IP

966

Q9Y6Y8
GVILYAESIDHSAWL

PROS1

336

P07225
DCDEWVAAIAHASYR

RASGRF1

116

Q13972
FEFVCSWLHSDLLTI

PLA2R1

836

Q13018
LYWACANGHAEVVTL

ANKRD30BL

76

A7E2S9
IVHLCAISLDRYWSI

ADRA2A

136

P08913
LAYSWEFTEAHVDAI

ANKDD1A

431

Q495B1
HSRTIYDIAWCQLTG

CIAO1

251

O76071
LAALVACSWYGHQIV

CLDN7

131

O95471
VLRWDYFTEQHAFSC

CHPF

391

Q8IZ52
VWIHVSVIYDQLCSV

CLEC7A

221

Q9BXN2
LIIIHWNACIYFAIS

CNGA3

311

Q16281
TADNIHYWLIADIIC

CNGB3

246

Q9NQW8
LSYLVVDEAHCVSQW

RECQL5

151

O94762
HASYWESADVVAFIL

PITPNM1

861

O00562
CRWDDSVTYIFHQLL

MRPL38

321

Q96DV4
WDVTVRTCAYTNHTV

PYGM

366

P11217
LEEAFTSEHWLVRIY

STT3B

756

Q8TCJ2
DVSWAVARLYHLLAE

TICAM1

91

Q8IUC6
VAIDFSHQEWEYLSL

ZNF607

11

Q96SK3
SLSSWICVEDIYAHI

PIEZO2

2361

Q9H5I5
SWQIVCSRLEEYNSH

TYR

271

P14679
VLYTLCAVSAALHWD

WDFY4

681

Q6ZS81
WYVAATVISIAHIDS

SLC4A5

891

Q9BY07
SLISEQWVVSAGHCY

PRSS2

51

P07478
SWETVCDSLDDYNHL

DCT

281

P40126
HDICYNSTTLWDVTV

nan

366

Q6ZUG5
HYFRSFWNCLDVVIV

PKD2

501

Q13563
LQEQHFWTLCSDVYV

SLC30A7

321

Q8NEW0
EEWDCLDSSQRHLYS

ZNF570

26

Q96NI8
TDACTEIWRQYHLTT

ZCCHC7

316

Q8N3Z6
ISDRWVLTAAHCLLY

F2

396

P00734
VDILWHCLVEDSECY

USP34

1011

Q70CQ2
YTEIIRIWDIVLDHC

TRANK1

891

O15050
LTICFCWHYAVTIVI

TMEM45A

221

Q9NWC5
FYALTWQTHLLALIC

SLC14A2

361

Q15849
WIRTCHNYFIEDLGL

TMX1

161

Q9H3N1
DRCLAWLAYIHLIEF

ZFC3H1

1521

O60293
RSDNTHYWLIISCSI

TMEM236

41

Q5W0B7
DDIHRSIKYNIWCST

YTHDF2

421

Q9Y5A9
DIHRSIKYSIWCSTE

YTHDF1

401

Q9BYJ9
LYSCSDDKHIVEWNV

WDR43

141

Q15061
EEWSLLSEAQRCLYH

ZNF776

26

Q68DI1
SELCVFWVLHFLSNS

ZNF302

106

Q9NR11
ARSICIHYVTTWFII

KCNH8

291

Q96L42
VTLTSYWEDISHRLD

MYOF

641

Q9NZM1
EWFTVLEHYRRTHCV

MYBPC3

1111

Q14896
KLESYWIEAQTLCHT

PPP1R9A

731

Q9ULJ8
LSLITFICEHLFYWQ

GRIN2B

831

Q13224